Hema Dave

556 total citations
27 papers, 241 citations indexed

About

Hema Dave is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Hema Dave has authored 27 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 8 papers in Immunology. Recurrent topics in Hema Dave's work include CAR-T cell therapy research (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Polyomavirus and related diseases (5 papers). Hema Dave is often cited by papers focused on CAR-T cell therapy research (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Polyomavirus and related diseases (5 papers). Hema Dave collaborates with scholars based in United States, Canada and Netherlands. Hema Dave's co-authors include Catherine M. Bollard, Miriam R. Anver, Donna Butcher, Elizabeth J. Shpall, Patrick J. Hanley, Alan S. Wayne, Carolina Colli Cruz, Sivasubramanian Baskar, Patrick O. Brown and Javed Khan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hema Dave

24 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hema Dave United States 9 150 72 56 50 40 27 241
Núria Martínez‐Cibrián Spain 9 189 1.3× 44 0.6× 63 1.1× 46 0.9× 41 1.0× 23 286
Viktoria Blumenberg Germany 10 304 2.0× 61 0.8× 51 0.9× 72 1.4× 29 0.7× 32 361
Victor A. Chow United States 8 214 1.4× 80 1.1× 50 0.9× 40 0.8× 77 1.9× 29 359
Maria A. V. Marzolini United Kingdom 9 229 1.5× 68 0.9× 59 1.1× 61 1.2× 33 0.8× 21 310
David M. Cordas dos Santos Germany 8 251 1.7× 82 1.1× 45 0.8× 34 0.7× 17 0.4× 16 304
Ana Cordeiro Brazil 5 332 2.2× 56 0.8× 47 0.8× 89 1.8× 17 0.4× 21 400
Brynn B. Duncan United States 9 204 1.4× 84 1.2× 106 1.9× 41 0.8× 42 1.1× 17 320
Matilde Sinibaldi Italy 8 199 1.3× 80 1.1× 181 3.2× 69 1.4× 34 0.8× 14 364
Ahmad Rayes United States 6 98 0.7× 96 1.3× 53 0.9× 25 0.5× 19 0.5× 11 271
Sebastian Ginzel Germany 11 85 0.6× 77 1.1× 186 3.3× 61 1.2× 37 0.9× 16 331

Countries citing papers authored by Hema Dave

Since Specialization
Citations

This map shows the geographic impact of Hema Dave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hema Dave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hema Dave more than expected).

Fields of papers citing papers by Hema Dave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hema Dave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hema Dave. The network helps show where Hema Dave may publish in the future.

Co-authorship network of co-authors of Hema Dave

This figure shows the co-authorship network connecting the top 25 collaborators of Hema Dave. A scholar is included among the top collaborators of Hema Dave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hema Dave. Hema Dave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forlenza, Christopher J., Audrey Mauguen, Ilia N. Buhtoiarov, et al.. (2023). Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma. Blood Advances. 7(13). 3225–3231. 3 indexed citations
2.
Gonzalez, Corina, Elliot Levy, Vladimir Valera, et al.. (2021). Case Report: Fatal Complications of BK Virus-Hemorrhagic Cystitis and Severe Cytokine Release Syndrome Following BK Virus-Specific T-Cells. Frontiers in Immunology. 12. 801281–801281. 16 indexed citations
3.
Abdel‐Azim, Hisham, Hema Dave, Kimberly R. Jordan, et al.. (2021). Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy. Cytotherapy. 24(2). 193–204. 2 indexed citations
4.
Balakrishnan, Preethi B., et al.. (2021). Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia. Molecular Therapy — Methods & Clinical Development. 23. 296–306. 13 indexed citations
5.
Dave, Hema, Melanie Grant, Maja Stanojević, et al.. (2021). Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma. Blood Advances. 6(2). 473–485. 13 indexed citations
6.
Forlenza, Christopher J., Audrey Mauguen, Ilia N. Buhtoiarov, et al.. (2021). Brentuximab Vedotin As Consolidation Therapy Following Autologous Stem Cell Transplantation in Children and Adolescents with Relapsed/Refractory Hodgkin Lymphoma: A Multi-Center Retrospective Analysis. Blood. 138(Supplement 1). 2465–2465. 3 indexed citations
7.
8.
Abraham, Allistair, Michael D. Keller, Carolina Colli Cruz, et al.. (2019). Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Advances. 3(14). 2057–2068. 33 indexed citations
9.
Dave, Hema, et al.. (2019). Driving the CAR to the Bone Marrow Transplant Program. Current Hematologic Malignancy Reports. 14(6). 561–569. 10 indexed citations
10.
Bollard, Catherine M., et al.. (2019). T-cell therapies for T-cell lymphoma. Cytotherapy. 21(9). 935–942. 7 indexed citations
11.
Dave, Hema, Donna Butcher, Miriam R. Anver, & Catherine M. Bollard. (2019). ROR1 and ROR2—novel targets for neuroblastoma. Pediatric Hematology and Oncology. 36(6). 352–364. 19 indexed citations
12.
Rossi, Christopher, et al.. (2019). Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemia. Pediatric Hematology and Oncology. 36(5). 309–316. 2 indexed citations
13.
Mehta, Rohtesh S., Hema Dave, Catherine M. Bollard, & Elizabeth J. Shpall. (2017). Engineering cord blood to improve engraftment after cord blood transplant. PubMed. 4(6). 41–41. 11 indexed citations
14.
Dave, Hema, Min Luo, Shabnum Patel, et al.. (2017). Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood. Molecular Therapy — Methods & Clinical Development. 5. 13–21. 35 indexed citations
15.
Dave, Hema, Min Luo, Shabnum Patel, et al.. (2017). Rapid Production of Multi-Virus Specific T Cells Targeting BKV, Adenovirus, CMV and EBV for Recipients of Umbilical Cord Blood Transplant. Biology of Blood and Marrow Transplantation. 23(3). S172–S172. 1 indexed citations
16.
Zamora, Carlos, et al.. (2014). The Role of Screening Sinus Computed Tomography in Pediatric Hematopoietic Stem Cell Transplant Patients. Journal of Computer Assisted Tomography. 39(2). 228–231. 5 indexed citations
17.
Shah, Nirali N., Hema Dave, & Alan S. Wayne. (2013). Immunotherapy for Pediatric Leukemia. Frontiers in Oncology. 3. 166–166. 8 indexed citations
18.
19.
Aggarwal, Anshita, et al.. (2002). Rituximab for the treatment of relapsing/refractory thrombotic thrombocytopenic purpura (TTP). Blood. 100(11). 1 indexed citations
20.
Shen‐Schwarz, Susan, Hema Dave, John M. Opitz, & James F. Reynolds. (1988). Meckel syndrome with polysplenia: Case report and review of the literature. American Journal of Medical Genetics. 31(2). 349–355. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Núria Martínez‐Cibrián Breakdown of academic impact, for papers by Viktoria Blumenberg Breakdown of academic impact, for papers by Victor A. Chow Breakdown of academic impact, for papers by Maria A. V. Marzolini Breakdown of academic impact, for papers by David M. Cordas dos Santos Breakdown of academic impact, for papers by Ana Cordeiro Breakdown of academic impact, for papers by Brynn B. Duncan Breakdown of academic impact, for papers by Matilde Sinibaldi Breakdown of academic impact, for papers by Ahmad Rayes Breakdown of academic impact, for papers by Sebastian Ginzel
Rankless by CCL
2026